Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Litemuppon Dec 02, 2016 2:21pm

26 Views

Post# 25547895

RE:Lvl 2 ...... 13 cents has fallen

Wow. That's impressive. Thx so much Mr Busy for keeping us informed.

Busyzzindahouse wrote:

LEVEL 2 QUOTE

Market Maker Shares Bid Price Ask Price Shares Market Maker

538,000 0.130 0.135 196,500

395,000 0.125 0.140 92,000

381,000 0.120 0.145 95,000

1,823,000 0.115 0.150 158,500

2,281,500 0.110 0.155 55,000

205,000 0.105 0.160 205,000

1,110,500 0.100 0.165 40,000

211,500 0.095 0.170 102,000

505,000 0.090 0.185 150,000

15,000 0.085 0.190 30,000

Shares	Bid Price	Ask Price	Shares
538,000	0.130	0.135	196,500
395,000	0.125	0.140	92,000
381,000	0.120	0.145	95,000
1,823,000	0.115	0.150	158,500
2,281,500	0.110	0.155	55,000
205,000	0.105	0.160	205,000
1,110,500	0.100	0.165	40,000
211,500	0.095	0.170	102,000
505,000	0.090	0.185	150,000
15,000	0.085	0.190	30,000